0910-AF79 200704 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Financial Disclosure by Clinical Investigators Other Significant Previously Published in The Unified Agenda Prerule Stage Undetermined No Section 610 Review 21 CFR 54 21 USC 321 21 USC 331 21 USC 351 21 USC 352 21 USC 353 21 USC 355 21 USC 360 21 USC 360c to 360j 21 USC 371 21 USC 372 21 USC 373 21 USC 374 21 USC 375 21 USC 376 21 USC 379 42 USC 262 Statutory Other 02/02/2006 Planned section 610 review No Begin Review of Current Regulation 12/01/2006 End Review 12/00/2007 No None No NA Not Collected Howard Muller P. 0910 Food and Drug Administration FDA 301 796-3601 301 847-8440 howard.mullerjr@fda.hhs.gov Suite 3037 (HFD-7), Center for Drug Evaluation and Research, WO 51, Room 6234, 10903 New Hampshire Avenue, Silver Spring MD 20993-0002 Stephen Ripley M. 0910 Food and Drug Administration FDA 301 827-6210 Suite 200N (HFM-17), Center for Biologics Evaluation and Research, 1401 Rockville Pike, Suite 200N (HFM-17), Rockville MD 20852-1448 Elisa Harvey D. 0910 Food and Drug Administration FDA 301 594-1190 106 301 594-3076 elisa.harvey@fda.hhs.gov Center for Devices and Radiological Health, Corp Room 130F (HFZ-215), 1350 Piccard Drive, Rockville MD 20850